Tdap, MenACWY, HPV, seasonal influenza, and COVID-19 vaccination status among US teens aged 13-17 years in 2022.

ABSTRACT:

Background

The Advisory Committee on Immunization Practices (ACIP) routinely recommends adolescents receive tetanus, diphtheria, and acellular pertussis (Tdap); meningococcal conjugate (MenACWY); and human papillomavirus (HPV) vaccines at age 11-12 years and routinely recommends influenza and COVID-19 vaccines annually for all adolescents, based on recommendations in 2023. We aimed to assess the overall proportion of US teens who are up-to-date (UTD) on receiving Tdap, MenACWY, and HPV vaccines by age 13 and the proportion who received seasonal influenza vaccine, the initial COVID-19 vaccination series and the initial COVID-19 booster. We also aimed to determine the relationship between multiple socio-demographic factors with the following: UTD status, and receipt of seasonal influ

SUBMITTER: Regmi NP 

PROVIDER: S-EPMC12461998 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature